Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse induced pluripotent stem cells.

Su H, Wang L, Huang W, Qin D, Cai J, Yao X, Feng C, Li Z, Wang Y, So KF, Pan G, Wu W, Pei D.

Stem Cell Res. 2013 May;10(3):338-48. doi: 10.1016/j.scr.2013.01.003. Epub 2013 Jan 13.

2.

Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.

Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM.

Stem Cells Transl Med. 2012 Feb;1(2):83-95. doi: 10.5966/sctm.2011-0022. Epub 2012 Feb 7.

3.

An Engineered N-Cadherin Substrate for Differentiation, Survival, and Selection of Pluripotent Stem Cell-Derived Neural Progenitors.

Haque A, Adnan N, Motazedian A, Akter F, Hossain S, Kutsuzawa K, Nag K, Kobatake E, Akaike T.

PLoS One. 2015 Aug 5;10(8):e0135170. doi: 10.1371/journal.pone.0135170. eCollection 2015.

4.

Differential effects of acellular embryonic matrices on pluripotent stem cell expansion and neural differentiation.

Yan Y, Martin LM, Bosco DB, Bundy JL, Nowakowski RS, Sang QX, Li Y.

Biomaterials. 2015 Dec;73:231-42. doi: 10.1016/j.biomaterials.2015.09.020. Epub 2015 Sep 12.

PMID:
26410789
5.

Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata.

Haque A, Yue XS, Motazedian A, Tagawa Y, Akaike T.

Biomaterials. 2012 Jul;33(20):5094-106. doi: 10.1016/j.biomaterials.2012.04.003. Epub 2012 Apr 19.

PMID:
22520296
6.

Directed neuronal differentiation of mouse embryonic and induced pluripotent stem cells and their gene expression profiles.

Chen X, Gu Q, Wang X, Ma Q, Tang H, Yan X, Guo X, Yan H, Hao J, Zeng F.

Int J Mol Med. 2013 Jul;32(1):25-34. doi: 10.3892/ijmm.2013.1372. Epub 2013 May 8.

PMID:
23652807
7.

Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.

Montgomery A, Wong A, Gabers N, Willerth SM.

Biomater Sci. 2015 Feb;3(2):401-13. doi: 10.1039/c4bm00299g. Epub 2014 Oct 16.

PMID:
26218131
8.

Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.

Choi HW, Kim JH, Chung MK, Hong YJ, Jang HS, Seo BJ, Jung TH, Kim JS, Chung HM, Byun SJ, Han SG, Seo HG, Do JT.

Stem Cells Dev. 2015 Jun 1;24(11):1366-73. doi: 10.1089/scd.2014.0561. Epub 2015 Apr 2.

PMID:
25590788
9.

A reduction in Npas4 expression results in delayed neural differentiation of mouse embryonic stem cells.

Klaric TS, Thomas PQ, Dottori M, Leong WK, Koblar SA, Lewis MD.

Stem Cell Res Ther. 2014 May 8;5(3):64. doi: 10.1186/scrt453.

10.

Efficient derivation of multipotent neural stem/progenitor cells from non-human primate embryonic stem cells.

Shimada H, Okada Y, Ibata K, Ebise H, Ota S, Tomioka I, Nomura T, Maeda T, Kohda K, Yuzaki M, Sasaki E, Nakamura M, Okano H.

PLoS One. 2012;7(11):e49469. doi: 10.1371/journal.pone.0049469. Epub 2012 Nov 14.

11.

Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells.

Koehler KR, Tropel P, Theile JW, Kondo T, Cummins TR, Viville S, Hashino E.

BMC Neurosci. 2011 Aug 10;12:82. doi: 10.1186/1471-2202-12-82.

12.

Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell.

Kwon YW, Chung YJ, Kim J, Lee HJ, Park J, Roh TY, Cho HJ, Yoon CH, Koo BK, Kim HS.

PLoS One. 2014 Jan 22;9(1):e85736. doi: 10.1371/journal.pone.0085736. eCollection 2014.

13.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O.

Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.

14.

Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.

Jeon K, Lim H, Kim JH, Thuan NV, Park SH, Lim YM, Choi HY, Lee ER, Kim JH, Lee MS, Cho SG.

Stem Cells Dev. 2012 Sep 20;21(14):2642-55. doi: 10.1089/scd.2011.0665. Epub 2012 Jun 1.

15.

Role of Jnk1 in development of neural precursors revealed by iPSC modeling.

Zhang Q, Mao J, Zhang X, Fu H, Xia S, Yin Z, Liu L.

Oncotarget. 2016 Sep 20;7(38):60919-60928. doi: 10.18632/oncotarget.11377.

16.

Derivation of Neural Stem Cells from Mouse Induced Pluripotent Stem Cells.

Karanfil I, Bagci-Onder T.

Methods Mol Biol. 2016;1357:329-38. doi: 10.1007/7651_2015_227.

PMID:
25863785
17.

Cdh2 stabilizes FGFR1 and contributes to primed-state pluripotency in mouse epiblast stem cells.

Takehara T, Teramura T, Onodera Y, Frampton J, Fukuda K.

Sci Rep. 2015 Sep 30;5:14722. doi: 10.1038/srep14722.

18.

Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells.

Badja C, Maleeva G, El-Yazidi C, Barruet E, Lasserre M, Tropel P, Binetruy B, Bregestovski P, Magdinier F.

Stem Cells Transl Med. 2014 Dec;3(12):1467-72. doi: 10.5966/sctm.2014-0024. Epub 2014 Oct 29.

19.

In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation.

Choi HW, Hong YJ, Kim JS, Song H, Cho SG, Bae H, Kim C, Byun SJ, Do JT.

PLoS One. 2017 Jan 31;12(1):e0170735. doi: 10.1371/journal.pone.0170735. eCollection 2017.

20.

Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.

Liu K, Ji G, Mao J, Liu M, Wang L, Chen C, Liu L.

Cell Reprogram. 2012 Dec;14(6):505-13. doi: 10.1089/cell.2012.0047. Epub 2012 Oct 4.

PMID:
23035653

Supplemental Content

Support Center